| Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study R Nejat, AS Sadr In Silico Pharmacology 9 (1), 2020 | 38 | 2020 |
| Synthesis, Molecular Docking, Molecular Dynamics Studies, and Biological Evaluation of 4H-Chromone-1,2,3,4-tetrahydropyrimidine-5-carboxylate Derivatives as … Z Dolatkhah, S Javanshir, AS Sadr, J Hosseini, S Sardari Journal of chemical information and modeling 57 (6), 1246-1257, 2017 | 33 | 2017 |
| In silico studies reveal structural deviations of mutant profilin-1 and interaction with riluzole and edaravone in amyotrophic lateral sclerosis AS Sadr, C Eslahchi, A Ghassempour, M Kiaei Scientific reports 11 (1), 6849, 2021 | 21 | 2021 |
| Diastereoselective synthesis and molecular docking studies of novel fused tetrahydropyridine derivatives as new inhibitors of HIV protease AA Mohammadi, S Taheri, A Amouzegar, R Ahdenov, MR Halvagar, ... Journal of Molecular Structure 1139, 166-174, 2017 | 18 | 2017 |
| Losartan Inhibits SARS-CoV-2 Replication in vitro: Losartan promotes cell survival following SARS-CoV-2 infection in vitro R Nejat, AS Sadr, B Freitas, J Crabttree, SD Pegan, RA Tripp, D Najafi Journal of Pharmacy & Pharmaceutical Sciences 24, 390-399, 2021 | 17 | 2021 |
| Binding interaction of spherical silver nanoparticles and calf thymus DNA: Comprehensive multispectroscopic, molecular docking, and RAPD PCR studies Z Talebpour, F Haghighi, M Taheri, M Hosseinzadeh, S Gharavi, F Habibi, ... Journal of Molecular Liquids 289, 111185, 2019 | 17 | 2019 |
| A predictive HQSAR model for a series of tricycle core containing MMP-12 inhibitors with dibenzofuran ring J Shamsara, A Shahir-Sadr International Journal of Medicinal Chemistry 2014, 2014 | 8 | 2014 |
| SARS virus papain-like protease: a mysterious weapon R Nejat, AS Sadr Journal of Biostatistics and Epidemiology 5 (4), 321-328, 2019 | 7 | 2019 |
| In silico and in vitro evaluation of cytotoxic activities of farnesiferol c and microlobin on MCF-7, HeLa and KYSE cell lines L Aldaghi, A Rad, A Arab, J Kasaian, M Iranshahi, AS Sadr, F Soltani Drug Research, 532-538, 2016 | 7 | 2016 |
| Developing a CoMSIA Model for Inhibition of COX-2 by resveratrol derivatives J Shamsara, A Shahir-Sadr Iranian Journal of Pharmaceutical Research: IJPR 15 (3), 459, 2016 | 4 | 2016 |
| Detection of structural and conformational changes in ALS-causing mutant profilin-1 with hydrogen/deuterium exchange mass spectrometry and bioinformatics techniques AS Sadr, Z Abdollahpour, A Aliahmadi, C Eslahchi, M Nekouei, L Kiaei, ... Metabolic Brain Disease 37 (1), 229-241, 2022 | 3 | 2022 |
| Synthesis and molecular docking studies of some new tetra-amide derivatives as new inhibitors of Maltase-Glucoamylase AA Mohammadi, S Taheri, AS Sadr, P Ghaderi, R Ahdenov Journal of Molecular Structure 1180, 556-563, 2019 | 3 | 2019 |
| A new chiral stationary phase based on noscapine: Synthesis, enantioseparation, and docking study Z Mousavimanesh, M Shahnani, A Faraji‐Shovey, M Bararjanian, ... Chirality 34 (10), 1371-1382, 2022 | 1 | 2022 |
| GPCRs of diverse physiologic and pathologic effects with fingerprints in COVID-19 R Nejat, AS Sadr, MF Torshizi, DJ Najafi Biology and Life Sciences Forum 7 (1), 19, 2021 | 1 | 2021 |
| Losartan promotes cell survival following SARS-CoV-2 infection in vitro R Nejat, AS Sadr, BT Freitas, J Crabtree, SD Pegan, RA Tripp, DJ Najafi bioRxiv, 2020.12. 27.424507, 2020 | 1 | 2020 |
| Erythropoietin in COVID-19-Induced Neuroinflammation; EPO Plus Losartan Might be Promising R Nejat, AS Sadr, D Najafi Journal of Biostatistics and Epidemiology, 2020 | 1 | 2020 |
| Daily Low Dose of Erythropoietin in Neuroinflammation; EPO Might Be Hazardous in COVID-19 R Nejat, AS Sadr, A Ebrahimi, A Nabati, E Eshaghi | 1 | 2020 |
| Daily Low Dose of Erythropoietin in Neuroinflammation R Nejat, AS Sadr, A Ebrahimi, A Nabati, E Eshaghi EPO Might Be Hazardous in COVID-19, 2020 | 1 | 2020 |
| Temporal arteritis: a case report HR SOHBATI, SA ARABANIAN, SA SHAHIR, S BALALAIE JOURNAL OF ARDABIL UNIVERSITY OF MEDICAL SCIENCES (JAUMS) 3 (9), 33-37, 2003 | 1 | 2003 |
| Evaluation of novel 2-(quinoline-2-ylthio) acetamide derivatives linked to diphenyl-imidazole as α-glucosidase inhibitors: Insights from in silico, in vitro, and in vivo … MK Ghomi, M Noori, M Mirahmad, A Iraji, AS Sadr, N Dastyafteh, P Asili, ... European Journal of Medicinal Chemistry 269, 116332, 2024 | | 2024 |
Shahrzad JavanshirAssociate professor of Organic chemistry, Iran University of Science and Technology (IUST)Verified email at iust.ac.ir
